Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006086 · ClinicalTrials.gov registry record · Phase 1
BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer
A Phase 1 study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00006086 is a Phase 1 study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute.
The verdict
NCT00006086, a Phase 1 study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of BMS-188797 and carboplatin in treating patients who have advanced nonhematologic cancer.
Interventions
- DRUG carboplatin
- DRUG BMS-188797
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006086
The ClinicalTrials.gov registry entry for NCT00006086 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which carboplatin is the first listed.
NCT00006086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006086 about?
NCT00006086 is a clinical study titled "BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of BMS-188797 and carboplatin in treating patients who have advanced nonh...
What is the current status of trial NCT00006086?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-06.
What interventions are being tested in trial NCT00006086?
The interventions under investigation include: carboplatin (DRUG), BMS-188797 (DRUG).
Who is sponsoring clinical trial NCT00006086?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.